Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.50 USD
Change Today +1.01 / 3.11%
Volume 585.8K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
As of 5:20 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - acorda therapeutics inc (ACOR)

Name (Connections)Board RelationshipsTitleKey Developments
Steven Rauscher M.B.A. 28 RelationshipsDirector, Chairman of Compliance Committee and Member of Audit Committee 
Ian Smith CPA, ACA 50 RelationshipsDirector, Chairman of Audit Committee and Member of Nominations & Governance Committee 
Lorin Randall 71 RelationshipsDirector, Member of Audit Committee, Member of Nominations & Governance Committee and Member of Compliance Committee 

Compensation Committee* - acorda therapeutics inc (ACOR)

Name (Connections)Board RelationshipsTitle
Barry Greene 42 RelationshipsDirector, Chairman of Ad Hoc Business Development Committee and Member of Compensation Committee
John Kelley MBA 37 RelationshipsDirector, Chairman of Compensation Committee and Member of Ad Hoc Business Development Committee
Sandra Panem Ph.D. 56 RelationshipsDirector, Chairman of Nominations & Governance Committee and Member of Compensation Committee
ACOR Compensation vs. Industry
745.8K
363.9K
Chief Executive Officer
403.3K
266.3K
Chief Financial Officer
312.7K
345.7K
Chief Operating Officer
Share price activity for ACORDA THERAPEUTICS INC (ACOR)
52 Week Price Performance
ACOR
Industry Average

Nominating Committee* - acorda therapeutics inc (ACOR)

Name (Connections)Board RelationshipsTitleKey Developments
Sandra Panem Ph.D. 56 RelationshipsDirector, Chairman of Nominations & Governance Committee and Member of Compensation CommitteeAcorda Therapeutics, Inc. Announces Executive Appointments
05/14/14
Ian Smith CPA, ACA 50 RelationshipsDirector, Chairman of Audit Committee and Member of Nominations & Governance CommitteeAcorda Therapeutics, Inc. Announces Executive Changes
10/7/13
Lorin Randall 71 RelationshipsDirector, Member of Audit Committee, Member of Nominations & Governance Committee and Member of Compliance CommitteeAcorda Therapeutics, Inc. Names Jane Wasman as President, International
10/9/12

Corporate Governance Committee* - acorda therapeutics inc (ACOR)

Name (Connections)Board RelationshipsTitle
Sandra Panem Ph.D. 56 RelationshipsDirector, Chairman of Ad Hoc Business Development Committee and Member of Compensation Committee
Lorin Randall 71 RelationshipsDirector, Chairman of Compensation Committee and Member of Ad Hoc Business Development Committee
Ian Smith CPA, ACA 50 RelationshipsDirector, Chairman of Nominations & Governance Committee and Member of Compensation Committee
ACOR and Competitor
Insiders vs. External
Board
5%
95%
Acorda Therapeutics, Inc.
25%
75%
DURECT Corporation
25%
75%
Isis Pharmaceuticals, Inc.
14%
86%
DepoMed Inc.
13%
87%
Impax Laboratories Inc.
0%
100%
ACADIA Pharmaceuticals Inc.
Insiders
External Board Members

Advisory Committee* - acorda therapeutics inc (ACOR)

Name (Board Relationships)/Title Board Affiliations
Michael Beattie 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Jacqueline Breshnahan 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Mary Bunge 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Carl Cotman 30 Relationships
Member of Scientific Advisory Board
No other board affiliations
James Fawcett 31 Relationships
Member of Scientific Advisory Board
No other board affiliations
Martin Grumet 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Eugene Johnson 43 Relationships
Member of Scientific Advisory Board
No other board affiliations
Mark Noble 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Melitta Schachner 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Jerry Silver 42 Relationships
Member of Scientific Advisory Board
No other board affiliations
Patrick Tresco 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Mark Tuszynski 31 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Waxman 28 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $33.50 USD +1.01

ACOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $41.98 USD +0.41
Depomed Inc $28.62 USD +7.98
Durect Corp $2.37 USD -0.03
Impax Laboratories Inc $47.52 USD -0.25
Isis Pharmaceuticals Inc $55.36 USD -0.07
View Industry Companies
 

Industry Analysis

ACOR

Industry Average

Valuation ACOR Industry Range
Price/Earnings 99.4x
Price/Sales 3.2x
Price/Book 2.5x
Price/Cash Flow 100.1x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.